Skip to main content Back to Top
Advertisement

11/15/2016

Multivitamin Oral Liquid

Products Affected - Description

    • Multi-Delyn oral liquid, Silarx, Adult, 237 mL bottle, 24 count, NDC 54838-0008-70
    • Multi-Delyn oral liquid, Silarx, Adult, 473 mL bottle, 12 count, NDC 54838-0008-80
    • Multi-Delyn with Iron oral liquid, Silarx, Adult, 237 mL bottle, 24 count, NDC 54838-0009-70
    • Multi-Delyn with Iron oral liquid, Silarx, Adult, 473 mL bottle, 12 count, NDC 54838-0009-80

Reason for the Shortage

    • Silarx (Lannett) discontinued all Multi-Delyn and Multi-Delyn with Iron oral liquid presentations in 2016.
    • Silarx (Lannett) did not provide a reason for the discontinuation.

Estimated Resupply Dates

    • Silarx (Lannett) has discontinued all Multi-Delyn and Multi-Delyn with Iron liquid presentations.

Updated

Created November 15, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins